Goserelin
Back to searchMolecule Structure
Scientific Name
Goserelin
Description of the Drug
Goserelin is a synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00014
http://www.drugbank.ca/drugs/DB00014
Brand Name(s)
Zoladex
Company Owner(s)
Tersera Therapeutics Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | AGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL19712239 | SCHEMBL20459194 | SCHEMBL8643 |
Human Metabolome Database | HMDB0014259 | ||
DrugBank | DB00014 | ||
PubChem: Thomson Pharma | 14841899 | ||
PubChem | 5311128 | ||
LINCS | LSM-46023 | ||
Nikkaji | J34.701I | ||
EPA CompTox Dashboard | DTXSID7048297 | ||
DrugCentral | 1327 | ||
Guide to Pharmacology | 3879 | ||
rxnorm | GOSERELIN | GOSERELIN ACETATE | ZOLADEX |
PubChem: Drugs of the Future | 12012688 | ||
ChEBI | 5523 |